US Nuclear Corp

Los Angeles, CA. November 20, 2018 – US Nuclear Corp. (OTCBB: UCLE)

• Sales for the three months ended September 30, 2018, were $1,145,480, an increase of 35.6% for the same period in 2017
• Gross profit was $512,096, an increase of 34% for the same period in 2017
• During the three months ended September 30, 2018, the company entered into an agreement with MIFTEC and paid $1,084,000 for certain manufacturing and supply rights as discussed below
• Net loss from operations ($1,414,715) due to stock-based compensation and acquisition of manufacturing and supply rights offset by an increase in gross profits due to higher sales (more…)

Los Angeles, CA. October 29, 2018 – US Nuclear Corp. (OTCBB: UCLE) recently reported strong worldwide revenue growth of 80% from 2016 based on the 2018 YTD sales rate. One main factor driving the growth in revenue is a targeted sales effort of US Nuclear’s unique signature products. These products include drinking water monitors, nuclear power plant air and stack monitors, USN/FlyCAM UAV DroneRADs, personnel and vehicle monitors, and tritium monitors.

US Nuclear Corp’s annual sales revenue for 2016 was $2,097,157 which rose to $3,070,646 for 2017.  The current 2018 YTD revenue for the first 3 quarters is $2,706,785, signifying a 2018 YTD sales rate of $3,600,000/year, an increase of 80% from 2016. Additionally, US Nuclear currently has a comfortable order backlog of $1,393,167.

Robert Goldstein, CEO of US Nuclear Corp, commented, “Looking forward, we are very optimistic.  We have focused our sales efforts on our signature product lines, which have been gaining momentum among our sales representatives and customers as they migrate to US Nuclear’s brand due to our superior reliability, performance, and innovative functionality and capabilities not found anywhere else.”

(more…)

Los Angeles, CA. September 13, 2018 – US Nuclear Corp (OTCBB: UCLE) recently attended and participated in the Urban Shield event from September 7-10, 2018 in the Bay Area.  Urban Shield is a disaster training exercise involving local, national, and international first responder agencies, including the national guard, police and fire departments, search & rescue, homeland security, FBI, FEMA, DOE, and many more.  The main goal of Urban Shield is to evaluate the preparedness and the capabilities of first responders in response to high-level threats in high-density areas and finding ways in which to improve.

US Nuclear Corp participated in an emergency service scenario wherein a car containing radioactive material had been blown up.  Radioactive sources were placed in/near the blown-up vehicle to create a live scenario. US Nuclear Corp and their drone partner FlyCam UAV flew FlyCam UAV’s NEO octocopter equipped with US Nuclear Corp’s radiation sensor search tool, the DroneRAD-ST, over the incident area to map the radioactive hotspots before emergency responders moved in to mitigate the situation.

FlyCam UAV’s NEO, a heavy-lifting, all-weather octocopter mounted with US Nuclear Corp’s Gamma Search Tool sensor is designed to detect radioactive Gamma emitting hotspots on the ground and log and transmit the GPS tagged data back in real-time.  The mission was successfully completed and the DroneRAD-ST mounted on FlyCam UAV’s NEO demonstrated its ability to measure and pinpoint the Gamma sources and overlay all the data on Google Maps. This provided first responders a real-time visual of the radioactive zones and where the concentration was the highest.  It was widely agreed by all the emergency service personnel present that the NEO mounted DroneRAD-ST is an essential tool that every first-responder service should have for emergencies involving radiation exposure.

US Nuclear Corp’s unique DroneRAD-ST was the only radiation and chemical detecting UAV mounted radiation sensor present at Urban Shield. As emergency services continue to improve, there will be a greater emphasis on acquiring the special tools needed to effectively address certain emergencies, especially in high-density areas.  This includes the DroneRAD-ST detector system mounted on FlyCam UAV’s drone platforms for quick surveying and mapping radiation-related emergencies thus mitigating first responder and public exposure to potentially harmful radiation.

Safe Harbor Act

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Investors may find additional information by visiting US Nuclear Corp. and the SEC website.

CONTACT:

US Nuclear Corp. (OTCBB: UCLE)
Robert I. Goldstein, President, CEO, and Chairman
Ph: (818) 883 7043
Email: info@usnuclearcorp.com
http://www.usnuclearcorp.com

Good news for Cancer and Heart Patients

Los Angeles, CA, Aug. 29, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — US Nuclear Corp. (UCLE):
US Nuclear Corporation’s partner recently achieved a significant milestone in nuclear fusion by exceeding 10¹⁰ neutrons per pulse with MIFTEC Fusion power technology designed for use in US Nuclear Isotope generator. This historic, high-level neutron flux is far above what any other fusion company has ever achieved, and is a large step towards the final goal of producing medical isotopes in a localized medical setting.

The method that US Nuclear Corp. and MIFTEC Laboratories Inc. are working to develop is simple, safe, and cost-effective. It uses an isotope of hydrogen as fuel, which is derived from seawater and is simple, safe, and cost-effective compared to the current method of using highly enriched or low enriched uranium (HEU/LEU) that results in dangerous, long-term radioactive byproducts.

With US Nuclear being designated as the exclusive manufacturer of the MIFTEC isotope generators. And, with the radiopharmaceutical market currently a $10B USD worldwide industry, US Nuclear Corp. and MIFTEC Laboratories, Inc. plans to be a major market participant upon reaching final testing and implementation.

(more…)

OPAL is a key part of the global supply of Mo-99, which is handled by a fragile network of isotope suppliers.  Fewer than a dozen nuclear reactors supply the entire world.  Unfortunately, these isotopes cannot be stockpiled due to the relatively short half-lives; Mo-99 has a half-life of 66 hours, while Tc-99m has a half-life of only 6 hours. There is already an enormous shortage of medical isotopes, and any production problems with current suppliers drastically exacerbate the situation.

A partnership between US Nuclear Corp. and MIFTEC aims to solve the global isotope shortage by manufacturing and selling medical isotope generators that can produce these isotopes at 50% of the current cost. MIFTEC is designing the medical isotope generator based off their parent company’s z-pinch fusion technique, which produces the high flux needed for isotope generation.  US Nuclear Corp., having over 70 years of manufacturing experience in the nuclear industry, was appointed the exclusive manufacturer for these isotope generators for N. America and Asia.